Aggressive diuresis for severe heart failure in the elderly

Chest

Volumn 119, Issue 3, 2001, Pages 807-810

  Howard, Patricia A ^a   Dunn, Marvin I ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Congestive heart failure; Economic saving; IV furosemide infusion

Indexed keywords

ARGININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE;

AGED; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; DIURESIS; DIURETIC THERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GERIATRIC DISORDER; HEART FAILURE; HUMAN; LENGTH OF STAY; MALE; MEDICARE; PRIORITY JOURNAL; REIMBURSEMENT;

EID: 0035096684     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.119.3.807     Document Type: Article

References (12)

1. Epidemiology, prevalence, treatments, and clinical trials: Treatment of heart failure: A managed care perspective
2. Consensus recommendations for the management of chronic heart failure: Evaluation of heart failure; clinical features
3. Refocus on diuretics in the treatment of heart failure
4. Combination diuretic therapy in severe congestive heart failure
5. Resistance to loop diuretics: Why it happens and what to do about it
6. High dose furosemide in the treatment of refractory congestive heart failure
7. Loop diuretics for chronic renal insufficiency: A continuous infusion is more efficacious than bolus therapy
8. Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance
9. Severe musculoskeletal symptoms during continuous infusion of bumetanide
10. The role of continuous infusion loop diuretics